Why these 4 ASX shares are ending the week in the red

The InvoCare Limited (ASX:IVC) share price is one of four ending the week in the red. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has fought back from a soft start and pushed higher in afternoon trade. At the time of writing the benchmark index is up 0.15% to 6,338.1 points.

Four shares that have failed to follow the market higher today are listed below. Here's why they are ending the week in the red:

The Estia Health Ltd (ASX: EHE) share price has fallen 4.5% to $2.99 a day after the release of its disappointing full-year results. One broker that wasn't overly impressed was Ord Minnett. Although the broker held firm with its hold rating, it reduced the price target on Estia Health's shares to $3.35 from $3.55. I thought its results were quite weak and would suggest investors avoid its shares for the time being.

The Evolution Mining Ltd (ASX: EVN) share price has dropped 4% to $2.73. This morning the gold miner released its full-year results and revealed a record underlying net profit after tax of $250.8 million, up 21% on FY 2017's result. While this was a strong result, the miner provided production guidance of 720,000 to 770,000 ounces of gold, down from 802,000 in FY 2018. It also forecast a reasonably sharp increase in its all-in sustaining costs.

The InvoCare Limited (ASX: IVC) share price has continued its decline and is down a further 3.5% to $12.70. The funeral company has come under pressure after the release of a soft half-year result yesterday accompanied with a downgrade to its full-year guidance. Analysts at Deutsche Bank didn't like what they saw and retained their sell rating and lowly $10.80 price target on its shares.

The Sonic Healthcare Limited (ASX: SHL) share price has dropped 2.5% to $25.64. On Thursday the healthcare company released its full-year results and posted an 8.3% increase in underlying EBITDA to $962 million. While this was in line with what analysts at Credit Suisse expected, the broker believes its valuation has become stretched now. As a result, it downgraded its shares to an underperform rating with a $23.50 price target.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended InvoCare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

a woman with lots of shopping bags looks upwards towards the sky as if she is pondering something.
Opinions

The pros and cons of buying Zip shares in 2026

There are positive and negative aspects about Zip shares right now…

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Buy, hold, sell: CBA, REA Group, and Xero shares

Morgans has given its verdict on these popular stocks. Let's see if it is bullish on them.

Read more »

A man in a suit looks serious while discussing business dealings with a couple as they sit around a computer at a desk in a bank home lending scenario.
Share Market News

Here's what Westpac says the RBA will do with interest rates in 2026

Stick or twist? Let's see what the RBA could do with rates this year.

Read more »

A woman stretches her arms into the sky as she rises above the crowd.
Best Shares

Fastest rising ASX 200 share of each market sector in 2025

These shares outperformed their sector peers last year.

Read more »

A couple stares at the tv in shock, with the man holding the remote up ready to press a button.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Aristocrat, James Hardie, and TechnologyOne shares

Morgans has given its verdict on these popular shares. Is it bullish, bearish, or something in between?

Read more »

Group of entrepreneurs feeling frustrated during a meeting in the office. Focus is on man with headache.
Share Fallers

5 worst ASX All Ords shares of 2025, and why brokers rate 4 of them a buy

The ASX All Ords rose by 7.11% in 2025 but as always, there were losers in the pack.

Read more »

A female soldier flies a drone using hand-held controls.
Best Shares

These 5 ASX All Ords shares were the fastest risers of 2025

The ASX All Ords rose by 7.11% and delivered total returns, including dividends, of 10.56% in 2025.

Read more »